JAZZ
Jazz Pharmaceuticals PLC
236.30$
+0.6%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 10.5% | 25.6% | 10.6% | 10.7% | 10.6% | 11.8% | 11.7% | 11.1% | 22.9% | 2.1% | 28.7% | 9.6% | 15.3% | |
| 89.5% | 74.4% | 89.4% | 89.3% | 89.4% | 88.2% | 88.3% | 88.9% | 77.1% | 97.9% | 71.3% | 90.4% | 84.7% | |
| 24.1% | 21.4% | 24.7% | 21.6% | 19.0% | 22.1% | 20.1% | 18.2% | 21.4% | 14.3% | 12.5% | 17.2% | 16.4% | |
| 31.7% | 39.1% | 39.0% | 33.1% | 30.9% | 33.9% | 57.2% | 34.3% | 47.1% | 33.9% | 33.0% | 32.2% | 36.5% | |
| 71.8% | 54.4% | 82.1% | 69.8% | 64.8% | 70.6% | 94.6% | 154.5% | 72.0% | 22.0% | 51.3% | 69.8% | 53.6% | |
| 17.7% | 20.0% | 7.3% | 19.5% | 24.7% | 17.5% | -6.2% | -65.6% | 5.1% | 75.9% | 20.0% | 20.5% | 31.1% | |
| 7.4% | 8.9% | 7.3% | 6.1% | 5.6% | 4.7% | 6.0% | 4.5% | 4.3% | 3.8% | 5.9% | 3.1% | 4.2% | |
| 10.2% | 6.1% | -0.3% | 13.5% | 19.0% | 12.2% | -12.3% | -70.3% | 0.8% | 17.4% | 28.0% | 17.5% | 15.8% | |
| -4.9% | -3.3% | 1.3% | -3.0% | -1.4% | -5.3% | -2.0% | -1.6% | -21.5% | 0.4% | 0.6% | 1.5% | -4.6% | |
| 15.1% | 9.3% | -1.6% | 16.5% | 20.4% | 17.6% | -10.3% | -68.7% | 22.3% | 17.0% | 27.4% | 16.0% | 20.4% | |
| 34.3% | 35.7% | 29.8% | 35.5% | 40.2% | 36.5% | 15.5% | -49.2% | 20.9% | 23.3% | 50.9% | 34.6% | 32.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.